EP1254265A4 - Methodes et materiaux concernant des polypeptides et des polynucleotides du type metallocarboxypeptidase - Google Patents

Methodes et materiaux concernant des polypeptides et des polynucleotides du type metallocarboxypeptidase

Info

Publication number
EP1254265A4
EP1254265A4 EP01907012A EP01907012A EP1254265A4 EP 1254265 A4 EP1254265 A4 EP 1254265A4 EP 01907012 A EP01907012 A EP 01907012A EP 01907012 A EP01907012 A EP 01907012A EP 1254265 A4 EP1254265 A4 EP 1254265A4
Authority
EP
European Patent Office
Prior art keywords
metallocarboxypeptidase
polynucleotides
polypeptides
methods
materials relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01907012A
Other languages
German (de)
English (en)
Other versions
EP1254265A1 (fr
Inventor
Bryan J Boyle
Nancy K Mize
Matthew C Arterburn
George Yeung
Y Tom Tang
Chenghua Liu
Radoje T Drmanac
Menq-Yun Wang
Lichuan Chen
Yea-Huey Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1254265A1 publication Critical patent/EP1254265A1/fr
Publication of EP1254265A4 publication Critical patent/EP1254265A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP01907012A 2000-02-03 2001-02-05 Methodes et materiaux concernant des polypeptides et des polynucleotides du type metallocarboxypeptidase Withdrawn EP1254265A4 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US676135 1984-11-29
US49691400A 2000-02-03 2000-02-03
US496914 2000-02-03
US56087500A 2000-04-27 2000-04-27
US560875 2000-04-27
US67613500A 2000-09-29 2000-09-29
PCT/US2001/003783 WO2001057265A1 (fr) 2000-02-03 2001-02-05 Methodes et materiaux concernant des polypeptides et des polynucleotides du type metallocarboxypeptidase

Publications (2)

Publication Number Publication Date
EP1254265A1 EP1254265A1 (fr) 2002-11-06
EP1254265A4 true EP1254265A4 (fr) 2004-06-30

Family

ID=27414041

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01907012A Withdrawn EP1254265A4 (fr) 2000-02-03 2001-02-05 Methodes et materiaux concernant des polypeptides et des polynucleotides du type metallocarboxypeptidase

Country Status (5)

Country Link
EP (1) EP1254265A4 (fr)
JP (1) JP2004515207A (fr)
AU (1) AU2001234848A1 (fr)
CA (1) CA2399672A1 (fr)
WO (1) WO2001057265A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002033088A2 (fr) * 2000-10-20 2002-04-25 Millennium Pharmaceuticals, Inc. 23566, 33489, et 57779, nouvelles carboxypeptidases humaines, scramblases, et nouveaux membres de la famille des protocadherines et leurs utilisations
JP2018194543A (ja) * 2017-05-12 2018-12-06 国立大学法人福井大学 アレルギー疾患の治療の効果を判定するためのキット、およびその利用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474901A (en) * 1991-02-01 1995-12-12 Genentech, Inc. Antibodies to human carboxypeptidase B and methods of use thereof
WO2002033088A2 (fr) * 2000-10-20 2002-04-25 Millennium Pharmaceuticals, Inc. 23566, 33489, et 57779, nouvelles carboxypeptidases humaines, scramblases, et nouveaux membres de la famille des protocadherines et leurs utilisations
WO2002081517A2 (fr) * 2001-01-19 2002-10-17 Curagen Corporation Nouveaux polypeptides et acides nucleiques codant pour ces derniers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1378571B1 (fr) * 1997-08-01 2011-01-12 Merck Serono Biodevelopment EST 5' pour proteines sécretées exprimées dans divers tissues

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474901A (en) * 1991-02-01 1995-12-12 Genentech, Inc. Antibodies to human carboxypeptidase B and methods of use thereof
US5593674A (en) * 1991-02-01 1997-01-14 Genentech, Inc. Plasma carboxypeptidase
WO2002033088A2 (fr) * 2000-10-20 2002-04-25 Millennium Pharmaceuticals, Inc. 23566, 33489, et 57779, nouvelles carboxypeptidases humaines, scramblases, et nouveaux membres de la famille des protocadherines et leurs utilisations
WO2002081517A2 (fr) * 2001-01-19 2002-10-17 Curagen Corporation Nouveaux polypeptides et acides nucleiques codant pour ces derniers

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 1 April 1990 (1990-04-01), "Mast cell carboxypeptidase A precursor (EC 3.4.17.1) (MC-CPA) (carboxypeptidase A3)", XP002278210, retrieved from EBI Database accession no. P15088 *
DATABASE EMBL [online] 2 January 2000 (2000-01-02), XP002278209, retrieved from EBI Database accession no. AC019052 *
See also references of WO0157265A1 *

Also Published As

Publication number Publication date
CA2399672A1 (fr) 2001-08-09
AU2001234848A1 (en) 2001-08-14
JP2004515207A (ja) 2004-05-27
EP1254265A1 (fr) 2002-11-06
WO2001057265A1 (fr) 2001-08-09

Similar Documents

Publication Publication Date Title
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1325120A4 (fr) Acides nucleiques et polypeptides
EP1276751A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1250346A4 (fr) Procedes et elements ayant trait a des polypeptides et des polynucleotides de type recepteurs couples a une proteine g
EP1252333A4 (fr) Procedes et substances relatifs a des polypeptides de type cd84 et a des polynucleotides
AUPQ976800A0 (en) Novel polypeptides and polynucleotides and uses therefor
IL153568A (en) Novel polypeptides and polynucleotides
EP1254266A4 (fr) Methodes et materiaux en rapport avec des polypeptides et de polynucleotides de type alpha-2-macroglobuline
EP1341803A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1254246A4 (fr) Methodes et matieres concernant des polypeptides et polynucleotides similaires a alpha de facteur de croissance de transformation
AU6762800A (en) Methods and materials relating to cd39-like polypeptides
IL140931A0 (en) Methods and materials relating to novel cd39-like polypeptides
AU3486501A (en) Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
AU2002360460A8 (en) Methods and materials relating to novel polypeptides and polynucleotides
EP1254265A4 (fr) Methodes et materiaux concernant des polypeptides et des polynucleotides du type metallocarboxypeptidase
EP1240178A4 (fr) Procedes et substances relatifs a des polypeptides de type prothrombinase et a des polynucleotides
EP1365801A4 (fr) Methodes et materiels se rapportant a des polypeptides et a des polynucleotides apparentes a la fibuline
AU2002359351A8 (en) Methods and materials relating to prokineticin-like polypeptides and polynucleotides
EP1409715A4 (fr) Procedes et materiaux concernant des polypeptides et des polynucleotides du type neurotrimin
EP1276902A4 (fr) Procedes et substances relatifs a des polypeptides de type antigene carcino-embryonnaire (cea) et a des polynucleotides
EP1261736A4 (fr) Methodes et materiaux associes a des polypeptides et des polynucleotides du type facteur-1 des preadipocytes (du type pref-1)
EP1268762A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1282635A4 (fr) Nouveaux acides nucleiques et polypeptides
GB0031021D0 (en) Polynucleotides and polypeptides
EP1242580A4 (fr) Procedes et substances relatifs a des polypeptides de type semaphorine et a des polynucleotides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020827

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12P 19/34 B

Ipc: 7C 12N 9/48 A

Ipc: 7C 12Q 1/68 B

Ipc: 7C 07H 21/04 B

Ipc: 7A 61K 39/395 B

Ipc: 7C 07K 5/00 B

A4 Supplementary search report drawn up and despatched

Effective date: 20040517

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040804